The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer.
A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.
Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.
An immunotherapy for some patients with advanced skin cancer and a targeted drug for some women with breast cancer have been approved for NHS Scotland.
Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.
Patients with a certain type of lung cancer will not have access to two targeted cancer drugs on the NHS in England.
A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England.
People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England.
Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.
Combining a targeted drug with hormone therapy could extend survival for some women with advanced breast cancer, according to new trial results.